Applied Therapeutics, Inc. Revenue
Applied Therapeutics, Inc. reported Revenue of $1.00 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2025-11-13
- Applied Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $1.00M, a 719.67% increase year-over-year.
- Applied Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Applied Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Applied Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-12-31 was $0.00.
- Applied Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $455.00K, a 95.45% decline from fiscal 2023.
- Applied Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $9.99M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2025-09-30 | $1.00M 10-Q · filed 2025-11-13 | $1.00M derived: sum of 2 quarters · filed 2025-11-13 | $1.00M 10-Q · filed 2025-11-13 | $1.00M derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | $0.00 derived: sum of 3 quarters · filed 2025-08-13 | $122.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | $0.00 derived: sum of 2 quarters · filed 2025-05-14 | $122.00K derived: sum of 3 quarters · filed 2025-11-13 | $266.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $122.00K derived: sum of 2 quarters · filed 2025-11-13 | $266.00K derived: sum of 3 quarters · filed 2025-11-13 | $455.00K 10-K · filed 2025-04-15 |
| 2024-09-30 | $122.00K 10-Q · filed 2025-11-13 | $266.00K derived: sum of 2 quarters · filed 2025-11-13 | $455.00K 10-Q · filed 2025-11-13 | -$211.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $144.00K 10-Q · filed 2025-08-13 | $334.00K 10-Q · filed 2025-08-13 | -$333.00K derived: sum of 3 quarters · filed 2025-08-13 | -$333.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $190.00K 10-Q · filed 2024-05-09 | -$477.00K derived: sum of 2 quarters · filed 2025-04-15 | -$477.00K derived: sum of 3 quarters · filed 2025-04-15 | -$477.00K derived: sum of 4 quarters · filed 2025-04-15 |
| 2023-12-31 | -$667.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$667.00K derived: sum of 2 quarters · filed 2025-04-15 | -$667.00K derived: sum of 3 quarters · filed 2025-04-15 | $9.99M 10-K · filed 2025-04-15 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $10.66M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $10.66M 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $10.66M 10-Q · filed 2024-05-09 |